Peddock Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Hold |
4,182
| – | – | 0.1% | 112 |
|
|
2025
Q1 | $422K | Buy |
4,182
+38
| +0.9% | +$3.83K | 0.11% | 110 |
|
|
2024
Q4 | $370K | Hold |
4,144
| – | – | 0.09% | 120 |
|
|
2024
Q3 | $347K | Sell |
4,144
-256
| -6% | -$21.5K | 0.08% | 126 |
|
|
2024
Q2 | $339K | Hold |
4,400
| – | – | 0.09% | 119 |
|
|
2024
Q1 | $301K | Hold |
4,400
| – | – | 0.08% | 132 |
|
|
2023
Q4 | $254K | Hold |
4,400
| – | – | 0.08% | 138 |
|
|
2023
Q3 | $232K | Hold |
4,400
| – | – | 0.08% | 132 |
|
|
2023
Q2 | $238K | Hold |
4,400
| – | – | 0.08% | 134 |
|
|
2023
Q1 | $220K | Hold |
4,400
| – | – | 0.08% | 142 |
|
|
2022
Q4 | $204K | Buy |
+4,400
| New | +$204K | 0.08% | 134 |
|
|
2021
Q3 | – | Sell |
-4,596
| Closed | -$210K | – | 142 |
|
|
2021
Q2 | $210K | Buy |
+4,596
| New | +$210K | 0.07% | 141 |
|
|
2021
Q1 | – | Sell |
-4,596
| Closed | -$165K | – | 168 |
|
|
2020
Q4 | $165K | Buy |
+4,596
| New | +$165K | 0.09% | 119 |
|
|
2020
Q2 | – | Sell |
-6,581
| Closed | -$215K | – | 103 |
|
|
2020
Q1 | $215K | Hold |
6,581
| – | – | 0.16% | 94 |
|
|
2019
Q4 | $298K | Hold |
6,581
| – | – | 0.15% | 89 |
|
|
2019
Q3 | $268K | Hold |
6,581
| – | – | 0.15% | 92 |
|
|
2019
Q2 | $283K | Hold |
6,581
| – | – | 0.15% | 88 |
|
|
2019
Q1 | $253K | Hold |
6,581
| – | – | 0.14% | 96 |
|
|
2018
Q4 | $233K | Sell |
6,581
-669
| -9% | -$23.7K | 0.14% | 95 |
|
|
2018
Q3 | $279K | Hold |
7,250
| – | – | 0.13% | 97 |
|
|
2018
Q2 | $237K | Hold |
7,250
| – | – | 0.12% | 105 |
|
|
2018
Q1 | $198K | Hold |
7,250
| – | – | 0.1% | 114 |
|
|
2017
Q4 | $180K | Hold |
7,250
| – | – | 0.09% | 119 |
|
|
2017
Q3 | $211K | Hold |
7,250
| – | – | 0.11% | 111 |
|
|
2017
Q2 | $201K | Buy |
+7,250
| New | +$201K | 0.11% | 113 |
|